Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer

Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T09:30:55.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2. No substantive changes to the study record or its presentation.
    Difference
    0.0%
    Check dated 2026-03-12T04:27:47.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous v3.4.1 revision plus a government funding status notice were removed. This update does not alter core study details or page content.
    Difference
    0.1%
    Check dated 2026-02-11T20:33:18.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A government funding lapse notice with operation-status information was added, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T10:44:51.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Introduces a Show glossary option and a Revision: v3.4.0 tag, and updates labels for QC criteria and the No FEAR Act notice with capitalization tweaks.
    Difference
    0.1%
    Check dated 2026-01-28T06:25:40.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown, replacing the previous Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T03:22:15.000Z thumbnail image

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.